Literature DB >> 22249081

Life expectancy and cardiovascular mortality in persons with schizophrenia.

Thomas M Laursen1, Trine Munk-Olsen, Mogens Vestergaard.   

Abstract

PURPOSE OF REVIEW: To assess the impact of cardiovascular disease on the excess mortality and shortened life expectancy in schizophrenic patients. RECENT
FINDINGS: Patients with schizophrenia have two-fold to three-fold higher mortality rates compared with the general population, corresponding to a 10-25-year reduction in life expectancy. Although the mortality rate from suicide is high, natural causes of death account for a greater part of the reduction in life expectancy. The reviewed studies suggest four main reasons for the excess mortality and reduced life expectancy. First, persons with schizophrenia tend to have suboptimal lifestyles including unhealthy diets, excessive smoking and alcohol use, and lack of exercise. Second, antipsychotic drugs may have adverse effects. Third, physical illnesses in persons with schizophrenia are common, but diagnosed late and treated insufficiently. Lastly, the risk of suicide and accidents among schizophrenic patients is high.
SUMMARY: Schizophrenia is associated with a substantially higher mortality and curtailed life expectancy partly caused by modifiable risk factors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249081     DOI: 10.1097/YCO.0b013e32835035ca

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  128 in total

1.  Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia.

Authors:  Jimmi Nielsen; Rasmus Røge; Sofie Gry Pristed; Anne Grethe Viuff; Henrik Ullum; Lise Wegner Thørner; Thomas Werge; Torkel Vang
Journal:  Schizophr Bull       Date:  2014-08-25       Impact factor: 9.306

2.  Bayesian semiparametric copula estimation with application to psychiatric genetics.

Authors:  Ori Rosen; Wesley K Thompson
Journal:  Biom J       Date:  2015-02-09       Impact factor: 2.207

3.  Perspectives of Overweight Latinos with Serious Mental Illness on Barriers and Facilitators to Health Behavior Change.

Authors:  Daniel E Jimenez; Kelly Aschbrenner; Kimberly Burrows; Sarah I Pratt; Margarita Alegría; Stephen J Bartels
Journal:  J Lat Psychol       Date:  2015-02

4.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

5.  Ageing and visual spatiotemporal processing.

Authors:  Karin S Pilz; Marina Kunchulia; Khatuna Parkosadze; Michael H Herzog
Journal:  Exp Brain Res       Date:  2015-05-20       Impact factor: 1.972

6.  Schizophrenia: overview and treatment options.

Authors:  Krishna R Patel; Jessica Cherian; Kunj Gohil; Dylan Atkinson
Journal:  P T       Date:  2014-09

Review 7.  Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia.

Authors:  Isabel Maurus; Alkomiet Hasan; Astrid Röh; Shun Takahashi; Boris Rauchmann; Daniel Keeser; Berend Malchow; Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-05-21       Impact factor: 5.270

8.  Preliminary Evaluation of Washington State's Early Intervention Program for First-Episode Psychosis.

Authors:  Oladunni Oluwoye; Hailey Reneau; Bryony Stokes; Rebecca Daughtry; Elizabeth Venuto; Tenaya Sunbury; Grace Hong; Barbara Lucenko; Bryan Stiles; Sterling M McPherson; Sarah Kopelovich; Maria Monroe-DeVita; Michael G McDonell
Journal:  Psychiatr Serv       Date:  2019-12-18       Impact factor: 3.084

9.  Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey.

Authors:  Carmen Moreno; Roberto Nuevo; Somnath Chatterji; Emese Verdes; Celso Arango; José Luis Ayuso-Mateos
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

10.  Health Care and Mortality among Persons with Severe Mental Illness.

Authors:  Gilad Gal; Hanan Munitz; Itzhak Levav
Journal:  Can J Psychiatry       Date:  2016-09-24       Impact factor: 4.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.